glp 1 semaglutide side effects π£ Ozempic β Ozempic, also called semaglutide, is a GLP-1 receptor medicine used for type 2 diabetes and sometimes weight management under medical supervision. β It helps improve blood sugar Oral GLP-1 Analogues (Semaglutide) -
Description
Eli Lillys Foundayo, a daily weight-loss pill, as well as Zepbound KwikPen, a weekly weight-loss injection, are covered, along with Novo Nordisks Wegovy weight-loss medication in both injection and pill forms

Ozempic and Wegovy use semaglutide, a GLP-1 medication
Managing Side Effects and When to Switch Medications or Adjust Dosing Most GLP-1 side effects peak during dose escalation and diminish within 2-4 weeks as your body adapts

Wegovy may contribute to an increased risk for thyroid c-cell tumors, acute pancreatitis, gallbladder disease, hypoglyceia, acute kidney injury, severe GI side effects, and an increased risk for worsening of diabetic retinopathy in people with type 2 diabetes

Barrera, J., Sandoval, D., DAlessio, D

Excess body weight increases chronic low-grade inflammation, which drives persistent HPA axis activation and elevated cortisol